Quality of Life During and After Completion of Neoadjuvant Chemoradiotherapy for Esophageal and Junctional Cancer

被引：0
|
作者：
B. J. Noordman
M. G. E. Verdam
B. Onstenk
J. Heisterkamp
W. J. B. M. Jansen
I. S. Martijnse
S. M. Lagarde
B. P. L. Wijnhoven
C. M. M. Acosta
A. van der Gaast
M. A. G. Sprangers
J. J. B. van Lanschot
机构：
[1] Erasmus MC – University Medical Centre Rotterdam,Department of Surgery
[2] Academic Medical Centre,Department of Medical Psychology
[3] Elisabeth-Tweesteden Hospital,Department of Surgery
[4] Erasmus MC – University Medical Centre Rotterdam,Department of Medical Oncology
来源：
Annals of Surgical Oncology | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4765 / 4772
页数：7
相关论文
共 50 条
  • [31] EUS T staging of esophageal cancer and outcome after neoadjuvant chemoradiotherapy.
    Jacobson, BC
    Mallery, S
    DeCamp, M
    Bueno, R
    Mentzer, SJ
    Sugarbaker, DJ
    Swanson, SJ
    Van Dam, J
    [J]. GASTROINTESTINAL ENDOSCOPY, 2000, 51 (04) : AB160 - AB160
  • [32] Residual Esophageal Cancer after neoadjuvant Chemoradiotherapy - Frequently involves the Mucosa and Submucosa
    Brink, F.
    Jaehne, J.
    [J]. CHIRURG, 2014, 85 (03): : 257 - 257
  • [33] Selecting esophageal cancer patients for lymphadenectomy after neoadjuvant chemoradiotherapy: a modeling study
    Scholte, Mirre
    de Gouw, Didi J. J. M.
    Klarenbeek, Bastiaan R.
    Grutters, Janneke P. C.
    Rosman, Camiel
    Rovers, Maroeska M.
    [J]. BMJ SURGERY INTERVENTIONS & HEALTH TECHNOLOGIES, 2020, 2 (01)
  • [34] Factors Associated with Pathologic Complete Response After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
    Liu, J.
    Zeng, X.
    Zhou, X.
    Xu, Y.
    Gong, Y.
    Wang, J.
    Zou, B.
    Zhou, L.
    Lu, Y.
    Liu, Y.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E55 - E55
  • [35] Residual Esophageal Cancer after Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa
    Shapiro, Joel
    ten Kate, Fiebo J. W.
    van Hagen, Pieter
    Biermann, Katharina
    Wijnhoven, Bas P. L.
    van Lanschot, J. Jan B.
    [J]. ANNALS OF SURGERY, 2013, 258 (05) : 678 - 689
  • [36] Tumor volume regression during neoadjuvant chemoradiotherapy for esophageal cancer on weekly MRI
    Defize, I.
    Boekhoff, M.
    Borggreve, A.
    Van Lier, A.
    Takahashi, N.
    Mohommad, N. Haj
    Ruurda, J.
    Van Hillegersberg, R.
    Mook, S.
    Meijer, G.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S923 - S923
  • [37] Neoadjuvant chemotherapy with or without neoadjuvant radiotherapy compared with neoadjuvant chemoradiotherapy for esophageal cancer
    Zheng, Yan
    Liu, Xianben
    Zhang, Ruixiang
    Wang, Zongfei
    Sun, Haibo
    Qin, Jianjun
    Liu, Shilei
    Li, Yin
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4715 - 4723
  • [38] Treatment strategies in recurrent esophageal or junctional cancer after neoadjuvant therapy followed by esophagectomy
    Butter, Rogier
    Lagarde, Sjoerd M.
    Anderegg, Maarten C. J.
    Gisbertz, Suzanne S.
    Meijer, Sybren L.
    Hulshof, Maarten
    Bergman, Jacques
    Henegouwen, Mark I. van Berge
    Van Laarhoven, Hanneke W. M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [39] Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy
    Lv, Yajuan
    Zhang, Jiandong
    Qiao, Lili
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (05) : 870 - 874
  • [40] Neoadjuvant Chemoradiotherapy in Esophageal Cancer: Is It Still the Question? Reply
    Tepper, Joel E.
    Niedzwiecki, Donna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (31) : 5134 - 5134
12345